Bailey D G, Bend J R, Arnold J M, Tran L T, Spence J D
Victoria Hospital, University of Western Ontario.
Clin Pharmacol Ther. 1996 Jul;60(1):25-33. doi: 10.1016/S0009-9236(96)90163-0.
To investigate a potentially marked effect by erythromycin on felodipine pharmacokinetics, to characterize the mechanism, and to compare the interaction with that between grapefruit juice and felodipine.
Felodipine, 10 mg extended release, was administered with 250 ml water, 250 mg erythromycin, or 250 ml grapefruit juice in a randomized crossover study of 12 healthy men. Erythromycin base, 250 mg four times a day, was started the day before and continued on that study day. Pharmacokinetic values of felodipine, the primary metabolite dehydrofelodipine, and the major secondary derivative M3 metabolite were studied.
Compared with water, erythromycin produced severalfold higher felodipine area under the plasma drug concentration-time profile (AUC), plasma peak drug concentration (Cmax), and apparent elimination half-life (t1/2); however, the effect was variable among individuals. Erythromycin augmented dehydrofelodipine AUC, Cmax, and t1/2 but decreased dehydrofelodipine/felodipine ratios. The AUC of the M3 metabolite and the M3 metabolite/dehydrofelodipine ratios were reduced. These findings support inhibition of both metabolic pathways likely mediated by CYP3A4. Grapefruit juice produced similar mean effects but did not prolong felodipine or dehydrofelodipine t1/2. Individually, felodipine AUC with erythromycin was greater than or similar to that with grapefruit juice. Relative felodipine AUC (erythromycin compared with grapefruit juice) correlated with relative felodipine Cmax but not with relative felodipine t1/2, suggesting felodipine AUC differed between these treatments, mainly from factors affecting presystemic drug elimination.
Erythromycin produced an important pharmacokinetic interaction with felodipine by inhibition of drug metabolism. Although erythromycin and grapefruit juice shared a common mechanism, erythromycin likely reduced felodipine biotransformation at the gut wall and liver, whereas single-dose grapefruit juice had an effect mainly at the gut wall.
研究红霉素对非洛地平药代动力学的潜在显著影响,阐明其作用机制,并比较与葡萄柚汁和非洛地平之间相互作用的异同。
在一项针对12名健康男性的随机交叉研究中,将10mg缓释非洛地平与250ml水、250mg红霉素或250ml葡萄柚汁一同服用。红霉素碱250mg,每日4次,在研究前一天开始服用并持续至研究当天。研究了非洛地平、主要代谢物脱氢非洛地平以及主要次要衍生物M3代谢物的药代动力学值。
与水相比,红霉素使非洛地平的血浆药物浓度-时间曲线下面积(AUC)、血浆药物峰值浓度(Cmax)和表观消除半衰期(t1/2)升高数倍;然而,个体间的效应存在差异。红霉素增加了脱氢非洛地平的AUC、Cmax和t1/2,但降低了脱氢非洛地平/非洛地平的比值。M3代谢物的AUC以及M3代谢物/脱氢非洛地平的比值降低。这些发现支持CYP3A4可能介导的两条代谢途径均受到抑制。葡萄柚汁产生了类似的平均效应,但未延长非洛地平或脱氢非洛地平的t1/2。单独来看,非洛地平与红霉素合用的AUC大于或类似于与葡萄柚汁合用的AUC。非洛地平AUC相对值(红霉素与葡萄柚汁相比)与非洛地平Cmax相对值相关,但与非洛地平t1/2相对值无关,表明这些治疗之间非洛地平AUC不同,主要源于影响药物首过消除的因素。
红霉素通过抑制药物代谢与非洛地平产生重要的药代动力学相互作用。尽管红霉素和葡萄柚汁有共同机制,但红霉素可能在肠道壁和肝脏降低非洛地平的生物转化,而单剂量葡萄柚汁的作用主要在肠道壁。